Skip to content

Clinical trials

Terminated Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Terminated Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20061
20073
20083
20091
20103
20113
20122
20136
20145
20153
20166
201711
20186
201913
20209
20216
20224
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated95

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Novartis Pharmaceuticals5
Bristol-Myers Squibb3
Genfit3
Alexion Pharmaceuticals, Inc.2
AstraZeneca2
Columbia University2
Duke University2
Emory University2
Indiana University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease95
Fatty Liver15
Fibrosis9
Liver Cirrhosis9
Obesity8
Liver Diseases7
Diabetes Mellitus, Type 26
Insulin Resistance5
Hepatitis C4
HIV Infections3

Trials

Showing 76 to 95 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.